HDL-C vs HDL-P: How Changing One Letter Could Make a Difference in Understanding the Role of High-Density Lipoprotein in Disease

疾病 高密度脂蛋白 脂蛋白 内科学 医学 动脉粥样硬化性心血管疾病 胆固醇 心理学
作者
W. Sean Davidson
出处
期刊:Clinical Chemistry [American Association for Clinical Chemistry]
卷期号:60 (11): e1-e3 被引量:26
标识
DOI:10.1373/clinchem.2014.232769
摘要

Before about 2006, most papers focusing on high-density lipoprotein (HDL)2 contained an introductory sentence that touted its protective role against cardiovascular disease (CVD), usually via the reverse transport of cholesterol away from the vessel wall. This was based on a mountain of epidemiological evidence showing an inverse correlation between plasma concentrations of HDL cholesterol (HDL-C) and CVD as well as thousands of in vitro and animal model studies demonstrating the cholesterol-carrying capacity of the particles. More recently, however, confidence in a direct atheroprotective role for HDL has wavered. HDL-targeted drugs such as niacin and 2 different cholesteryl ester transfer protein (CETP) inhibitors have failed in clinical trials, despite raising HDL-C (nicely reviewed in (1)). Furthermore, recent Mendelian randomization analyses suggest that genetic anomalies that raise HDL-C fail to impart the CVD protections predicted by epidemiologic findings (2). This has prompted some to regard HDL as a marker or byproduct of other, more directly atheroprotective, mechanisms. On the other hand, large studies have shown that the cholesterol efflux capacity of primarily HDL-containing [i.e., low-density lipoprotein (LDL)-depleted] serum is a robust predictor of CVD, even better than HDL-C (3), suggesting that HDL's mobilization of cellular cholesterol may indeed be atheroprotective. So why has it been so difficult to determine whether HDL plays a direct protective role in CVD? Some argue that the picture has been clouded by the way HDL has been traditionally quantified. The HDL-C measurement targets only a single HDL component, and a relatively minor one at that: a maximum of 20% of HDL mass is cholesterol or its ester. Ideally, one would like to know the actual number of HDL particles (HDL-P) circulating in plasma, not simply how much cholesterol they are carrying. This is a relatively easy determination for LDL. Because each particle contains a single copy …
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我爱科研完成签到 ,获得积分10
1秒前
余味应助科研通管家采纳,获得10
13秒前
laber应助科研通管家采纳,获得30
13秒前
余味应助科研通管家采纳,获得10
13秒前
余味应助科研通管家采纳,获得10
13秒前
陶世立完成签到 ,获得积分10
15秒前
16秒前
16秒前
Raymond完成签到,获得积分10
23秒前
小糊涂仙儿完成签到 ,获得积分10
23秒前
Owen应助Jeffery426采纳,获得10
26秒前
LinglongCai完成签到 ,获得积分10
31秒前
乐天林完成签到 ,获得积分10
33秒前
阳炎完成签到,获得积分10
35秒前
akanenn999完成签到,获得积分10
39秒前
提莫silence完成签到 ,获得积分10
40秒前
Boris完成签到 ,获得积分10
41秒前
光亮若翠完成签到,获得积分10
43秒前
柚子完成签到 ,获得积分10
45秒前
李天浩完成签到 ,获得积分10
45秒前
deng203完成签到 ,获得积分10
46秒前
新威宝贝完成签到,获得积分0
48秒前
北有云烟完成签到 ,获得积分10
49秒前
ybheart完成签到,获得积分10
49秒前
50秒前
木又完成签到 ,获得积分10
51秒前
小柒柒完成签到,获得积分10
53秒前
lorentzh完成签到,获得积分10
53秒前
绿色心情完成签到 ,获得积分10
54秒前
缓慢雅青完成签到 ,获得积分10
1分钟前
NorthWang完成签到,获得积分10
1分钟前
i2stay完成签到,获得积分10
1分钟前
茉莉雨完成签到 ,获得积分10
1分钟前
WittingGU完成签到,获得积分0
1分钟前
Owen应助Hyy采纳,获得10
1分钟前
1分钟前
炸鸡完成签到 ,获得积分10
1分钟前
碧蓝丹烟完成签到 ,获得积分10
1分钟前
1分钟前
小白白完成签到 ,获得积分10
1分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Les Mantodea de Guyane Insecta, Polyneoptera 2500
Computational Atomic Physics for Kilonova Ejecta and Astrophysical Plasmas 500
Technologies supporting mass customization of apparel: A pilot project 450
Brain and Heart The Triumphs and Struggles of a Pediatric Neurosurgeon 400
Cybersecurity Blueprint – Transitioning to Tech 400
Mixing the elements of mass customisation 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3782730
求助须知:如何正确求助?哪些是违规求助? 3328104
关于积分的说明 10234493
捐赠科研通 3043122
什么是DOI,文献DOI怎么找? 1670450
邀请新用户注册赠送积分活动 799702
科研通“疑难数据库(出版商)”最低求助积分说明 758994